New Antibody Shows Promise Against Gammaherpesviruses
A newly discovered antibody, Fab5, is showing promise in neutralizing a broad range of gammaherpesviruses, including Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus, according to research published in Nature. Gammaherpesviruses are a subfamily of herpesviruses known for causing various diseases and malignancies in humans and other vertebrate animals. Currently, there are no specific antiviral agents available to target each type or the entire family of these viruses.
The research highlights Fab5's mechanism of action against gB, a fusion protein vital for herpesvirus infection. According to the Nature article, gB is a common protein and an ideal target for broad vaccine development. The study reports the molecular basis for broad gB binding and cross-genus virus neutralization by the antibody Fab5.
In addition to this development, multiple news sources reported on a range of other scientific and health-related issues. These include the potential use of Beauveria bassiana fungal strains as a biocontrol for bark beetles. Concerns were also raised about potential political interference in appointments at the National Institutes of Health (NIH). Other news items included Asda's financial challenges, the Crans-Montana bar fire investigation, and low public awareness regarding alcohol as a carcinogen. Furthermore, the unearthing of a massive archaeological collection during HS2 railway construction was also reported.
Discussion
AI Experts & Community
Be the first to comment